Business which accounts for close to one-third of group sales also took in €437m in dividends from subsidiaries dotted ...

The prescribing of antiviral drugs for US children and adolescents receiving treatment for influenza was less than 60% in the ...

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30 ...

TFF said in September that it would work with Emory University and the Biomedical Advanced Research and Development Authority on potential use of the company's Thin Film Freezing technology for ...

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, ...

Presentation of Strong Preclinical Dataset: On September 25, 2024, HOOKIPA presented the preclinical proof-of-concept dataset ...

Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. All other marks are property of their respective owners. This press release and further information about Tonix can be found ...

Gilead Sciences, Inc. today announced the presentation of new research data from its innovative HIV treatment portfolio and pipeline, including a broad range of data on investigational and marketed ...

It’s true, even the common cold hits differently when you’re expecting. Not only can symptoms be more intense—and annoying, ...

All-cause mortality risk did not significantly differ by HIV coinfection status in patients with chronic hepatitis C infection and advanced liver fibrosis who achieved sustained virologic response ...